CVE-2026-6053
Multiple vulnerabilities have been discovered in IBM products. Some of them allow an attacker to cause remote arbitrary code execution, privilege escalation, and a remote denial of service.
CSIRTS triage
- What
- Multiple vulnerabilities can allow remote arbitrary code execution, privilege escalation, and remote denial of service.
- Who is affected
- Users of IBM products.
- Urgency
- Remediation urgency is unclear but should be prioritized due to potential impacts.
- Action
- Monitor for updates from IBM regarding these vulnerabilities.
AI-assisted analysis generated from the source advisory — verify against the original.
⚡ Watch CVE-2026-6053
Get an email if CVE-2026-6053 is added to CISA KEV, gains public exploit code, or a new advisory cites it — max one per day, one-click unsubscribe.
Exploitation outlook
- Low exploitation risk0.10% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 1% of all EPSS-scored CVEs.
Advisory coverage (1)
- unknownMultiple vulnerabilities in IBM products (July 3, 2026)cert-fr-avis · 2026-07-03
External references
Embed the live status
— this badge updates automatically when the KEV or exploit status changes. How to embed it →
[](https://www.csirts.com/cve/CVE-2026-6053)